Lymphoplasmacytic Lymphoma Recruiting Phase 1 Trials for Fludarabine (DB01073)

IndicationStatusPhase
DBCOND0031072 (Lymphoplasmacytic Lymphoma)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04545762Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin LymphomaTreatment